| Kathleen M Chaisson, MD | |
|
130 Division St, Derby, CT 06418-1326 | |
| (203) 732-7573 | |
| (203) 732-7418 |
| Full Name | Kathleen M Chaisson |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 130 Division St, Derby, Connecticut |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932130259 | NPI | - | NPPES |
| 001424085 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 042408 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Griffin Hospital | Derby, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Specialties, P.c. | 8628169539 | 2 |
News Archive
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs").
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.
› Verified 2 days ago
| Entity Name | Griffin Faculty Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs").
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.
› Verified 2 days ago
| Entity Name | Pulmonary Specialties, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437354560 PECOS PAC ID: 8628169539 Enrollment ID: O20070807000618 |
News Archive
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs").
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen M Chaisson, MD 130 Division St, Derby, CT 06418-1326 Ph: (203) 732-7573 | Kathleen M Chaisson, MD 130 Division St, Derby, CT 06418-1326 Ph: (203) 732-7573 |
News Archive
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI's high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs").
Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.
Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, with live training kit demos at Milipol Paris 2009.
Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.
› Verified 2 days ago
Genevieve Cecile Kela, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7327 | |
Dr. Gerald George Fette, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 | |
Dr. Howard Quentzel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7439 Fax: 203-732-1425 | |
Mukesh Kumar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 Fax: 203-732-1332 | |
Earl Lewin Baker, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 130 Division Street, Derby, CT 06418 Phone: 203-735-7421 | |
Aartee Deshpande, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-1330 | |
Mark S Grogan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division Street, Derby, CT 06418 Phone: 203-732-7455 Fax: 203-735-5507 |